| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/14/2023 | -15.73% | B of A Securities | $4 → $1.5 | Downgrades | Buy → Underperform |
| 09/26/2022 | 237.08% | B. Riley Securities | $8 → $6 | Maintains | Buy |
| 09/26/2022 | 12.36% | Stifel | $3 → $2 | Maintains | Sell |
| 08/09/2022 | 152.81% | B of A Securities | $6.5 → $4.5 | Upgrades | Neutral → Buy |
| 08/02/2022 | 152.81% | Evercore ISI Group | $7.5 → $4.5 | Downgrades | Outperform → In-Line |
| 06/06/2022 | 293.26% | Credit Suisse | $8 → $7 | Maintains | Outperform |
| 04/01/2022 | 349.44% | Credit Suisse | $5.5 → $8 | Upgrades | Neutral → Outperform |
| 08/23/2021 | 293.26% | Morgan Stanley | $8 → $7 | Maintains | Equal-Weight |
| 08/11/2021 | 208.99% | Credit Suisse | $6 → $5.5 | Maintains | Neutral |
| 07/08/2021 | 349.44% | B. Riley Securities | → $8 | Initiates Coverage On | → Buy |
| 06/08/2021 | 237.08% | Credit Suisse | $2 → $6 | Maintains | Neutral |
| 06/08/2021 | 293.26% | Evercore ISI Group | $3 → $7 | Upgrades | In-Line → Outperform |
| 06/07/2021 | 349.44% | Morgan Stanley | → $8 | Upgrades | Underweight → Equal-Weight |
| 06/01/2021 | 208.99% | Scotiabank | $3 → $5.5 | Maintains | Sector Perform |
| 05/25/2021 | 147.19% | DNB Markets | → $4.4 | Upgrades | Hold → Buy |
| 03/26/2021 | 12.36% | Morgan Stanley | $6 → $2 | Maintains | Underweight |
| 01/21/2021 | 180.9% | Wolfe Research | → $5 | Upgrades | Peer Perform → Outperform |
| 06/02/2020 | -94.38% | Stifel | $8 → $0.1 | Downgrades | Hold → Sell |
| 03/12/2020 | — | Credit Suisse | Downgrades | Outperform → Neutral | |
| 03/12/2020 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 03/09/2020 | 12.36% | Baird | $5 → $2 | Downgrades | Outperform → Neutral |
| 09/20/2019 | 237.08% | Morgan Stanley | → $6 | Initiates Coverage On | → Underweight |
| 09/18/2019 | 686.52% | Evercore ISI Group | → $14 | Initiates Coverage On | → Outperform |
| 08/27/2019 | 574.16% | Raymond James | $13 → $12 | Maintains | Outperform |
| 07/17/2019 | 405.62% | Stifel | $16 → $9 | Downgrades | Buy → Hold |
| 03/12/2019 | 1023.6% | BTIG | → $20 | Initiates Coverage On | → Buy |
| 02/28/2019 | 630.34% | Credit Suisse | $12 → $13 | Maintains | Outperform |
| 02/13/2019 | 574.16% | Raymond James | → $12 | Initiates Coverage On | → Outperform |
| 11/14/2018 | 574.16% | Credit Suisse | $15 → $12 | Maintains | Outperform |
| 10/11/2018 | 742.7% | Credit Suisse | → $15 | Initiates Coverage On | → Outperform |
| 09/26/2018 | — | Cowen & Co. | Downgrades | Outperform → Market Perform | |
| 09/17/2018 | 855.06% | Baird | $15 → $17 | Maintains | Outperform |
| 08/15/2018 | 742.7% | Baird | → $15 | Initiates Coverage On | → Outperform |
| 08/09/2018 | 686.52% | Stifel | $15 → $14 | Maintains | Buy |
| 03/22/2018 | 742.7% | Stifel | $16 → $15 | Maintains | Buy |
What is the target price for Tellurian (TELL)?
The latest price target for Tellurian (AMEX: TELL) was reported by B of A Securities on February 14, 2023. The analyst firm set a price target for $1.50 expecting TELL to fall to within 12 months (a possible -15.73% downside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tellurian (TELL)?
The latest analyst rating for Tellurian (AMEX: TELL) was provided by B of A Securities, and Tellurian downgraded their underperform rating.
When is the next analyst rating going to be posted or updated for Tellurian (TELL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tellurian, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tellurian was filed on February 14, 2023 so you should expect the next rating to be made available sometime around February 14, 2024.
Is the Analyst Rating Tellurian (TELL) correct?
While ratings are subjective and will change, the latest Tellurian (TELL) rating was a downgraded with a price target of $4.00 to $1.50. The current price Tellurian (TELL) is trading at is $1.78, which is out of the analyst's predicted range.